Literature DB >> 28476230

Genetics of Adrenocortical Development and Tumors.

Maya Lodish1.   

Abstract

This article links the understanding of developmental physiology of the adrenal cortex to adrenocortical tumor formation. Many molecular mechanisms that lead to formation of adrenocortical tumors have been discovered via next-generation sequencing approaches. The most frequently mutated genes in adrenocortical tumors are also factors in normal adrenal development and homeostasis, including those that alter the p53 and Wnt/β-catenin pathways. In addition, dysregulated protein kinase A signaling and ARMC5 mutations have been identified as key mediators of adrenocortical tumorigenesis. The growing understanding of genetic changes that orchestrate adrenocortical development and disease pave the way for potential targeted treatment strategies. Published by Elsevier Inc.

Entities:  

Keywords:  Adrenal development; Adrenocortical carcinoma; Driver mutation; Genetic; Ontogenesis; Pathway; Signaling; Zonation

Mesh:

Substances:

Year:  2017        PMID: 28476230      PMCID: PMC5424622          DOI: 10.1016/j.ecl.2017.01.007

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  78 in total

1.  The role of fibroblast growth factor receptor 4 overexpression and gene amplification as prognostic markers in pediatric and adult adrenocortical tumors.

Authors:  Luciana Pinto Brito; Tamaya Castro Ribeiro; Madson Q Almeida; Alexander Augusto de Lima Jorge; Iberê Cauduro Soares; Ana Claudia Latronico; Berenice Bilharinho Mendonca; Maria Candida Barisson Villares Fragoso; Antonio Marcondes Lerario
Journal:  Endocr Relat Cancer       Date:  2012-05-03       Impact factor: 5.678

2.  Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells.

Authors:  Silvia Monticone; Namita G Hattangady; Koshiro Nishimoto; Franco Mantero; Beatrice Rubin; Maria Verena Cicala; Raffaele Pezzani; Richard J Auchus; Hans K Ghayee; Hirotaka Shibata; Isao Kurihara; Tracy A Williams; Judith G Giri; Roni J Bollag; Michael A Edwards; Carlos M Isales; William E Rainey
Journal:  J Clin Endocrinol Metab       Date:  2012-05-24       Impact factor: 5.958

3.  Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors.

Authors:  Frédérique Tissier; Catherine Cavard; Lionel Groussin; Karine Perlemoine; Gwladys Fumey; Anne-Marie Hagneré; Fernande René-Corail; Eric Jullian; Christine Gicquel; Xavier Bertagna; Marie-Cécile Vacher-Lavenu; Christine Perret; Jérôme Bertherat
Journal:  Cancer Res       Date:  2005-09-01       Impact factor: 12.701

4.  (Epi)genotype-phenotype correlations in Beckwith-Wiedemann syndrome.

Authors:  Alessandro Mussa; Silvia Russo; Agostina De Crescenzo; Andrea Freschi; Luciano Calzari; Silvia Maitz; Marina Macchiaiolo; Cristina Molinatto; Giuseppina Baldassarre; Milena Mariani; Luigi Tarani; Maria Francesca Bedeschi; Donatella Milani; Daniela Melis; Andrea Bartuli; Maria Vittoria Cubellis; Angelo Selicorni; Margherita Cirillo Silengo; Lidia Larizza; Andrea Riccio; Giovanni Battista Ferrero
Journal:  Eur J Hum Genet       Date:  2015-04-22       Impact factor: 4.246

5.  Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d'etude des Tumeurs Endocrines database.

Authors:  B Gatta-Cherifi; O Chabre; A Murat; P Niccoli; C Cardot-Bauters; V Rohmer; J Young; B Delemer; H Du Boullay; M F Verger; J M Kuhn; J L Sadoul; Ph Ruszniewski; A Beckers; M Monsaingeon; E Baudin; P Goudet; A Tabarin
Journal:  Eur J Endocrinol       Date:  2011-11-14       Impact factor: 6.664

6.  Identification of novel genetic variants in phosphodiesterase 8B (PDE8B), a cAMP-specific phosphodiesterase highly expressed in the adrenal cortex, in a cohort of patients with adrenal tumours.

Authors:  Anya Rothenbuhler; Anelia Horvath; Rossella Libé; Fabio R Faucz; Amato Fratticci; Marie L Raffin Sanson; Delphine Vezzosi; Monalisa Azevedo; Isaak Levy; Madson Q Almeida; Maya Lodish; Maria Nesterova; Jérôme Bertherat; Constantine A Stratakis
Journal:  Clin Endocrinol (Oxf)       Date:  2012-08       Impact factor: 3.478

7.  Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity.

Authors:  Jerome Bertherat; Lionel Groussin; Fabiano Sandrini; Ludmila Matyakhina; Thalia Bei; Sotirios Stergiopoulos; Theocharis Papageorgiou; Isabelle Bourdeau; Lawrence S Kirschner; Caroline Vincent-Dejean; Karine Perlemoine; Christine Gicquel; Xavier Bertagna; Constantine A Stratakis
Journal:  Cancer Res       Date:  2003-09-01       Impact factor: 12.701

8.  Cancer Risk in Beckwith-Wiedemann Syndrome: A Systematic Review and Meta-Analysis Outlining a Novel (Epi)Genotype Specific Histotype Targeted Screening Protocol.

Authors:  Alessandro Mussa; Cristina Molinatto; Giuseppina Baldassarre; Evelise Riberi; Silvia Russo; Lidia Larizza; Andrea Riccio; Giovanni Battista Ferrero
Journal:  J Pediatr       Date:  2016-06-29       Impact factor: 4.406

9.  ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner.

Authors:  Huai-Xiang Hao; Yang Xie; Yue Zhang; Olga Charlat; Emma Oster; Monika Avello; Hong Lei; Craig Mickanin; Dong Liu; Heinz Ruffner; Xiaohong Mao; Qicheng Ma; Raffaella Zamponi; Tewis Bouwmeester; Peter M Finan; Marc W Kirschner; Jeffery A Porter; Fabrizio C Serluca; Feng Cong
Journal:  Nature       Date:  2012-04-29       Impact factor: 49.962

10.  Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors.

Authors:  Gerald Goh; Ute I Scholl; James M Healy; Murim Choi; Manju L Prasad; Carol Nelson-Williams; John W Kunstman; John W Kuntsman; Reju Korah; Anna-Carinna Suttorp; Dimo Dietrich; Matthias Haase; Holger S Willenberg; Peter Stålberg; Per Hellman; Göran Akerström; Peyman Björklund; Tobias Carling; Richard P Lifton
Journal:  Nat Genet       Date:  2014-04-20       Impact factor: 38.330

View more
  6 in total

Review 1.  Pathological and Genetic Stratification for Management of Adrenocortical Carcinoma.

Authors:  Michael R Clay; Emilia M Pinto; Lauren Fishbein; Tobias Else; Katja Kiseljak-Vassiliades
Journal:  J Clin Endocrinol Metab       Date:  2022-03-24       Impact factor: 5.958

2.  Nutlin-3a as a novel anticancer agent for adrenocortical carcinoma with CTNNB1 mutation.

Authors:  Wen Hui; Shenghua Liu; Jie Zheng; Zujun Fang; Qiang Ding; Chenchen Feng
Journal:  Cancer Med       Date:  2018-03-13       Impact factor: 4.452

3.  Incidence of adrenal gland tumor as a second primary malignancy: SEER-based study.

Authors:  Wafaa M Rashed; Anas M Saad; Muneer J Al-Husseini; Ahmed Mahmoud Galal; Assem Mohamed Ismael; Ahmed M Al-Tayep; Ayman El Shafie; Mahmoud Ahmed Ali; Ahmed Samir Alfaar
Journal:  Endocr Connect       Date:  2018-08-23       Impact factor: 3.335

4.  Adrenocortical carcinoma in a young adult male with chronic urticaria: A case report and literature review.

Authors:  Yasmin Moussa; Mohamad Moussa; Mohamed Abou Chakra
Journal:  Int J Surg Case Rep       Date:  2019-12-26

Review 5.  The Role of Biomarkers in Adrenocortical Carcinoma: A Review of Current Evidence and Future Perspectives.

Authors:  Maja Mizdrak; Tina Tičinović Kurir; Joško Božić
Journal:  Biomedicines       Date:  2021-02-10

6.  Feminizing adrenocortical adenoma in a girl from a resource-limited setting: a case report.

Authors:  Eman Abdalla Ali Elnaw; Areej Ahmed Bashier Ibrahim; Mohamed Ahmed Abdullah
Journal:  J Med Case Rep       Date:  2021-12-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.